TCWP’s Gilead Sciences GILD Stock Holding History

TCWP’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-1,575	Closed	-$93K	–	840
2022 Q1	$93K	Buy	+1,575	New	+$101K	0.02%	362

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

TCWP's GILD Position: Q2 2022 in Review

TCWP sold out of Gilead Sciences (GILD) in Q2 2022, closing a stake of 1,575 shares — an estimated $93K sold.

TCWP first reported a position in GILD in Q1 2022 and held it in 1 quarter. The position peaked at $93K in Q1 2022. 1,603 funds tracked by Wall St. Rank hold GILD as of Q2 2022.

TCWP reported no remaining Gilead Sciences position as of Q2 2022 after selling out during the quarter.
TCWP sold 1,575 Gilead Sciences shares in Q2 2022, an estimated $93K.
TCWP first reported a position in Gilead Sciences in Q1 2022 and held it in 1 quarter.
TCWP's Gilead Sciences position peaked at $93K in Q1 2022.
1,603 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2022.

Based on TCWP's 13F filing for Q2 2022, filed 15 Aug 2022.